0001209191-17-014942.txt : 20170227
0001209191-17-014942.hdr.sgml : 20170227
20170227182511
ACCESSION NUMBER: 0001209191-17-014942
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170223
FILED AS OF DATE: 20170227
DATE AS OF CHANGE: 20170227
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AERIE PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001337553
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 203109565
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 7020 KIT CREEK ROAD
STREET 2: SUITE 270
CITY: RESEARCH TRIANGLE PARK
STATE: NC
ZIP: 27709
BUSINESS PHONE: 919-313-9650
MAIL ADDRESS:
STREET 1: 7020 KIT CREEK ROAD
STREET 2: SUITE 270
CITY: RESEARCH TRIANGLE PARK
STATE: NC
ZIP: 27709
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: RUBINO RICHARD J
CENTRAL INDEX KEY: 0001252014
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36152
FILM NUMBER: 17643785
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2017-02-23
0
0001337553
AERIE PHARMACEUTICALS INC
AERI
0001252014
RUBINO RICHARD J
C/O AERIE PHARMACEUTICALS, INC.
2030 MAIN STREET, SUITE 1500
IRVINE
CA
92614
0
1
0
0
Chief Financial Officer
Common Stock
2017-02-23
4
A
0
4780
0.00
A
403912
D
Common Stock
2017-02-24
4
F
0
932
44.55
D
402980
D
Common Stock
2017-02-25
4
F
0
845
44.55
D
402135
D
Stock Option (right to buy)
44.25
2017-02-23
4
A
0
43019
0.00
A
2027-02-23
Common Stock
43019
43019
D
These shares of Common Stock are scheduled to vest, subject to the reporting person's continued employment with the issuer through the applicable vesting date, in equal installments on each of the first four anniversaries of February 23, 2017.
This option is scheduled to vest, subject to the reporting person's continued employment with the issuer through the applicable vesting date, in equal installments on each of the first 48 monthly anniversaries of February 23, 2017.
/s/ Richard J. Rubino
2017-02-27